Research Article | Open Access
Bo Liang, Liyun Liu, Huibin Huang, Liangyi Li, Jingxiong Zhou, "High T3 Induces β-Cell Insulin Resistance via Endoplasmic Reticulum Stress", Mediators of Inflammation, vol. 2020, Article ID 5287108, 7 pages, 2020. https://doi.org/10.1155/2020/5287108
High T3 Induces β-Cell Insulin Resistance via Endoplasmic Reticulum Stress
Hyperthyroidism can cause glucose metabolism disorders and insulin resistance. Insulin resistance in muscle and adipose tissues has been extensively studied, whereas investigations on β-cell insulin resistance are limited. This study preliminarily explored the effects of high T3 levels on β-cell line (MIN6) insulin resistance, as well as the roles of endoplasmic reticulum stress (ERS). In this study, we treated β-cell line with T3, with or without an inhibitor of phosphotyrosine phosphatases (PTPs, sodium vanadate) or ERS inhibitor (4-PBA). The results indicated that high levels of T3 significantly inhibited insulin secretion in β-cell line. In addition, we observed an upregulation of p-IRS-1ser307 and downregulation of Akt. These results can be corrected by sodium vanadate. Moreover, high T3 levels upregulate the ERS-related proteins PERK, IRE1, ATF6, and GRP78, as well as ERS-related apoptosis CHOP and caspase-12. Similarly, this change can be corrected by 4-PBA. These results suggest that high T3 levels can induce insulin resistance in β-cell line by activating ERS and the apoptotic pathway.
About 70% to 75% of hyperthyroidism cases are associated with glucose metabolism disorders and insulin resistance [1, 2]. The effect of thyroid hormones on glucose metabolism is mainly through T3, which binds to T3 receptors in β-cell nuclei and regulates insulin signal transduction as well as secretion [3, 4]. However, the mechanism of high T3 levels on insulin resistance in β-cells has not been elucidated.
The endoplasmic reticulum is an organelle in eukaryotic cells, except for mammalian red blood cells, that is mainly responsible for the synthesis, processing, and secretion of proteins, as well as the metabolism of lipids and sugars . A variety of adverse factors can block the synthesis and processing of proteins, such as chemical toxicants, high glucose, low temperature, and hypoxia . These factors can cause unfolded or misfolded proteins to accumulate in the ER cavity and induce endoplasmic reticulum stress (ERS) [7, 8]. A growing body of evidence suggests that insulin resistance in β-cells induced by ERS affects insulin signal transduction [9, 10]. All of these pathways can inhibit insulin signal transduction and cause insulin resistance [11, 12]. In addition, ERS induced the upregulation of CHOP and caspase-12, which cause β-cell apoptosis in diabetes . The purpose of this study was to investigate the effects of high T3 levels on insulin signal transduction, insulin secretion in β-cells, and the role of ERS in this process.
2. Materials and Methods
The MIN6 cell line was obtained from the Institute of Basic Medicine, Chinese Academy of Medical Sciences (Beijing, China). Liothyronine sodium (T3 or liothyronine) was purchased from Suzhou Famu Biomedical Technology Co., Ltd. (Suzhou, China), sodium orthovanadate (an inhibitor of phosphotyrosine phosphatases) was purchased from Shanghai Macklin Biochemical Co., Ltd. (Shanghai, China), and phenylbutyric acid (4-PBA) was obtained from Sigma (USA). Western blot reagents were obtained from Cell Signaling Technology (CST, USA), and cell culture materials were obtained from Thermos.
2.2. Cell Culture
MIN6 cells were cultured in DMEM with 10% fetal bovine serum in a 37°C incubator with 5% CO2. The culture medium was replaced every two days, and the cells were routinely passaged every seven days. Cells were harvested for assays when cell confluency reached 100%.
2.3. CCK8 Assay
In this study, different concentrations of T3 were used to stimulate MIN6 cells, and then, the CCK8 method was used to detect the effect of T3 on the activity of MIN6 cells.
2.4. Cell Treatment with Liothyronine Sodium
When the cells reached 100% confluency, liothyronine sodium was added into the culture medium at a concentration of 5 pg/mL or 20 pg/mL (final concentration) and was designated as normal- or high-concentration FT3 treatment group (N or H group). All of the treatments were continuously cultured for 48 h.
2.5. Administration of Sodium Orthovanadate and 4-PBA
Sodium orthovanadate (final concentration: 5 μmol/L) and ERS inhibitor 4-PBA (final concentration 1 mmol/L) were independently applied to the H group for 48 h .
2.6. Western Blot Analysis
Protein samples were prepared as follows: cell pellets were lysed with cold RIPA cleavage buffer and centrifuged at 12,000 g for 20 min at 4°C, and protein concentrations were determined using the BCA method. After electrophoresis with 10% polyacrylamide gel, the proteins were transferred onto a PVDF membrane using standard semidry transblot procedures. After blocking with 5% BSA in PBS for 2 h at room temperature, the membrane was incubated with a primary antibody overnight at 4°C. After three washes with TBST buffer, the membrane was incubated with HRP-conjugated goat anti-rabbit IgG or goat anti-mouse IgG for 1 h at room temperature. After extra washes with TBST buffer, the membrane was developed using the standard ECL method.
2.7. Enzyme-Linked Immunosorbent Assay
The culture media of the cell plates were transferred into EP tubes. The supernatants were centrifuged at 1,000 rpm for 5 min and then placed into an EP tube. Insulin concentrations were measured using the mouse insulin enzyme-linked immunosorbent assay (ELISA) kit (ExCell Bio. Co., Ltd., Shanghai, China).
2.8. Statistical Analysis
SPSS 21.0 software was employed for statistical analysis. Statistical analysis was performed using Student’s -test when comparing two groups or ANOVA with Bonferroni post hoc test when comparing three or more groups. Differences with p <0.05 were considered to be statistically significant.
3.1. The Effect of Different Concentrations of T3 on the Activity of MIN6 Cells
The results of the CCK8 test showed that when the concentration of T3 was lower than 80 pg/mL, the cell activity was not significantly affected (Figure 1).
3.2. High T3 Induces Insulin Resistance in Pancreatic Cells
Different concentrations of T3 were used to treat islet β-cells. Then, we collected the total proteins of these cells. Western blotting analysis showed that compared with the normal-concentration T3 group, the high-concentration T3 group exhibited an upregulation of IRS-1ser307 and downregulation of Akt (Figure 2(a)). Then, we used ELISA to detect the insulin content in the MIN6. ELISA results showed that high concentrations of T3 decrease insulin secretion in islet β-cells. Those processes were reversed by sodium orthovanadate by inhibiting insulin resistance (Figures 2(b) and 2(c)).
3.3. High T3 Induces Insulin Resistance via ERS in Pancreatic Cells
We treated MIN6 cells with T3 and 4-PBA, respectively, and collected the proteins of these cells. Western blotting analysis showed that compared with the normal-concentration T3 group, the high-concentration T3 group exhibited an increase in the expression of GRP78, PERK, IRE1, and ATF6, which are specific proteins of the ERS (Figure 3(a)). As mentioned above, high concentrations of T3 upregulated IRS-1ser307, downregulated Akt, and decreased the insulin secretion of islet β-cells. These processes were all reversed by 4-PBA, an inhibitor of ERS (Figures 3(b)–3(d)).
3.4. High T3 Induces ERS-Associated Apoptosis in Pancreatic Cells
Western blotting analysis showed that compared with the normal-concentration T3 group, the high-concentration T3 group exhibited increased expression of CHOP and caspase-12, which are special apoptosis-related proteins of the ERS (Figure 4(a)). These processes were reversed by 4-PBA (Figure 4(b)).
Studies have shown that glucose metabolic disorders and insulin resistance are common in patients with hyperthyroidism . High levels of T3 can cause peripheral insulin resistance in the liver and adipose tissues . However, studies on insulin resistance in cells induced by high T3 levels are limited. β-cells secreting insulin are regulated by insulin signal transduction. Insulin resistance in β-cells can result in a decrease in insulin secretion . Insulin receptor substrate (IRS-1) is an important target of the insulin signal transduction pathway in β-cells and plays an important role in the development of insulin resistance. Insulin resistance is not the only factor. There are many factors leading to β-cell death. But previous studies have shown that insulin resistance can cause severe apoptosis [17, 18]. And this study only focused on insulin resistance.
Activation of IRS-1 wild-type β-cells could induce insulin secretion in β-cells, but insulin secretion could not be detected in IRS-1-/-β-cells [19–21]. Currently, serine phosphorylation at the ser307 site of IRS-1 has been extensively studied. When serine phosphorylation at the ser307 site of IRS-1 is activated, tyrosine phosphorylation is inhibited and blocks the insulin signal transduction pathway. Therefore, IRS-1ser307 increased, but insulin secretion of pancreatic β-cells decreased. . Akt, also known as PKB, is also an important target in the insulin signal transduction pathway . Activated Akt can phosphorylate many substrates and promote insulin secretion. When insulin resistance occurs, Akt expression is downregulated. Our study found that the expression of p-IRS-1ser307 in the high-level T3 group increased, while the expression of Akt decreased. The fact that sodium vanadate, an inhibitor of phosphorylation of IRS-1ser307, can recover insulin secretion indicates that high levels of T3 can inhibit insulin signal transduction in β-cells via the IRS-1/PI3-K/Akt pathway and result in insulin resistance [14, 24]. To reveal whether high levels of T3 lead to ERS, we detected ERS marker proteins and ERS apoptosis marker proteins. We found that high levels of T3 significantly increase the expression of ERS characteristic proteins PERK, IRE1, ATF6, and GRP78 as well as ERS apoptosis marker proteins CHOP and caspase-12 and could be corrected by the ERS inhibitor 4-PBA. The results show that high levels of T3 could induce β-cell ERS and apoptosis.
Our study was mainly carried out in MIN6 cell line. Previous studies showed that insulin secretion of β-cell line MIN6 increased significantly at high glucose concentration, and its insulin secretion and S-type response curve were similar to those of normal islet cells. Further studies on insulin secretion, glucose transport, glycooxidative phosphorylation, and glucose utilization of insulin β-cell line MIN6 showed that the cell components in MIN6 cells that regulate glucose concentration-dependent insulin secretion are similar to normal islets in quality and quantity [25, 26].
During ERS, the PERK-eIF2 α pathway is activated, and the expression of ATF4 is increased, which leads to the upregulation of TRB3 expression. As a negative feedback regulator of the insulin signal transduction pathway, TRB3 can affect the insulin signal transduction pathway by inhibiting the function of Akt, which then causes insulin resistance . PKR can be activated by ERS, which not only directly inhibits tyrosine phosphorylation of IRS-1ser307 and causes insulin resistance but also reduces the phosphorylation of Akt by activating JNK and inhibits insulin signal transduction, indirectly leading to insulin resistance. In this study, after the application of ERS inhibitor 4-PBA, ERS was relieved, whereas IRS-1ser307 was significantly downregulated, the expression of Akt was significantly upregulated, and insulin secretion also increased. These findings suggest that high levels of T3 can induce insulin resistance and decrease β-cell insulin secretion via ERS.
When ERS is too strong, the apoptosis signal pathway is initiated. This is an independent apoptotic pathway. CHOP and caspase-12 are specific apoptotic proteins that are related to ERS [12, 28, 29]. High levels of T3 lead to the significant upregulation of CHOP and caspase-12, which further indicates that high levels of T3 can induce β-cell apoptosis through ERS and result in a decrease in insulin secretion in β-cells. This may also be an indirect mechanism for insulin resistance in β-cells.
In sum, our study suggests that high levels of T3 can induce ERS and result in insulin resistance and insulin secretion in β-cells, thereby contributing to the pathogenesis of diabetes.
The data used to support the findings of this study are available from the corresponding authors upon request.
Conflicts of Interest
The authors have no conflicts of interest to declare.
Bo Liang and Liyun Liu contributes equally to this work.
We thank Xiaoshan Chen for technical support. We thank LetPub (http://www.letpub.com) for its linguistic assistance during the preparation of this manuscript. This work was supported by the Youth Scientific Research Project of Fujian Provincial Health Commission China (2016-1-63), the Natural Science Foundation of Fujian Province (2017J01273), and Innovative Medical Research Project of Fujian Province (2018-CX-33).
- C. Wang, “The relationship between type 2 diabetes mellitus and related thyroid diseases,” Journal Diabetes Research, vol. 2013, article 390534, pp. 1–9, 2013.
- L. Yang, X. Shen, S. Yan, X. Yuan, J. Lu, and W. Wei, “HbA1c in the diagnosis of diabetes and abnormal glucose tolerance in patients with Graves' hyperthyroidism,” Diabetes Research and Clinical Practice, vol. 101, no. 1, pp. 28–34, 2013.
- A. Assmann, K. Ueki, J. N. Winnay, T. Kadowaki, and R. N. Kulkarni, “Glucose effects on beta-cell growth and survival require activation of insulin receptors and insulin receptor substrate 2,” Molecular and Cellular Biology, vol. 29, no. 11, pp. 3219–3228, 2009.
- C. Verga Falzacappa, E. Petrucci, V. Patriarca et al., “Thyroid hormone receptor TRβ1 mediates Akt activation by T3 in pancreatic β cells,” Journal of Molecular Endocrinology, vol. 38, no. 2, pp. 221–233, 2007.
- W. Guo, J. Liu, J. Sun et al., “Butyrate alleviates oxidative stress by regulating NRF2 nuclear accumulation and H3K9/14 acetylation via GPR109A in bovine mammary epithelial cells and mammary glands,” Free Radical Biology & Medicine, vol. 152, pp. 728–742, 2020.
- B. Luo and A. S. Lee, “The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies,” Oncogene, vol. 32, no. 7, pp. 805–818, 2013.
- X. Wang, C. O. Eno, B. J. Altman et al., “ER stress modulates cellular metabolism,” The Biochemical Journal, vol. 435, no. 1, pp. 285–296, 2011.
- W. Guo, B. Liu, Y. Yin et al., “Licochalcone a protects the blood-milk barrier integrity and relieves the inflammatory response in LPS-induced mastitis,” Frontiers in Immunology, vol. 10, p. 287, 2019.
- M. Swetha and K. V. A. Ramaiah, “Insulin treatment promotes tyrosine phosphorylation of PKR and inhibits polyIC induced PKR threonine phosphorylation,” Archives of Biochemistry and Biophysics, vol. 585, pp. 98–108, 2015.
- B. Guan, L. Wang, L. Ma, X. Liu, and L. Liu, “Effects of exendin-4 on endoplasmic reticulum stress-mediated insulin resistance in 3T3-L1 adipocytes,” Acta Endocrinologica, vol. 15, no. 2, pp. 158–164, 2019.
- L. Huang, H. Xie, and H. Liu, “Endoplasmic reticulum stress, diabetes mellitus, and tissue injury,” Current Protein & Peptide Science, vol. 15, no. 8, pp. 812–818, 2014.
- K. Meyerovich, F. Ortis, F. Allagnat, and A. K. Cardozo, “Endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation,” Journal of Molecular Endocrinology, vol. 57, no. 1, pp. R1–R17, 2016.
- D. R. Laybutt, A. M. Preston, M. C. Akerfeldt et al., “Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes,” Diabetologia, vol. 50, no. 4, pp. 752–763, 2007.
- A. S. Tracey, “Hydroxamido vanadates: aqueous chemistry and function in protein tyrosine phosphatases and cell cultures,” Journal of Inorganic Biochemistry, vol. 80, no. 1-2, pp. 11–16, 2000.
- B. Ujwal Upadya, M. N. Suma, K. M. Srinath, A. Prashant, P. Doddamani, and S. V. Shilpa, “Effect of insulin resistance in assessing the clinical outcome of clinical and subclinical hypothyroid patients,” Journal of Clinical and Diagnostic Research, vol. 9, no. 2, pp. 1–4, 2015.
- K. Ağbaht, M. F. Erdogan, R. Emral, N. Baskal, and S. Güllü, “Circulating glucagon to ghrelin ratio as a determinant of insulin resistance in hyperthyroidism,” Endocrine, vol. 45, no. 1, pp. 106–113, 2014.
- C. N. Huang, C. J. Wang, C. L. Lin, A. T. Yen, H. H. Li, and C. H. Peng, “Abelmoschus esculentus subfractions attenuate beta amyloid-induced neuron apoptosis by regulating DPP-4 with improving insulin resistance signals,” PLoS One, vol. 14, no. 6, article e0217400, 2019.
- H. S. Park, H. S. Cho, and T. W. Kim, “Physical exercise promotes memory capability by enhancing hippocampal mitochondrial functions and inhibiting apoptosis in obesity-induced insulin resistance by high fat diet,” Metabolic Brain Disease, vol. 33, no. 1, pp. 283–292, 2018.
- R. N. Kulkarni, M. G. Roper, G. Dahlgren et al., “Islet secretory defect in insulin receptor substrate 1 null mice is linked with reduced calcium signaling and expression of sarco (endo) plasmic reticulum Ca2+-ATPase (SERCA)-2b and -3,” Diabetes, vol. 53, no. 6, pp. 1517–1525, 2004.
- M. Ohsugi, C. Cras-Méneur, Y. Zhou et al., “Reduced expression of the insulin receptor in mouse insulinoma (MIN6) cells reveals multiple roles of insulin signaling in gene expression, proliferation, insulin content, and secretion,” The Journal of Biological Chemistry, vol. 280, no. 6, pp. 4992–5003, 2005.
- G. G. Xu, Z. Y. Gao, P. D. Borge Jr., P. A. Jegier, R. A. Young, and B. A. Wolf, “Insulin regulation of β-cell function involves a feedback loop on SERCA gene expression, Ca2+ homeostasis, and insulin expression and secretion†,” Biochemistry, vol. 39, no. 48, pp. 14912–14919, 2000.
- V. Aguirre, T. Uchida, L. Yenush, R. Davis, and M. F. White, “The c-Jun NH (2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser (307),” The Journal of Biological Chemistry, vol. 275, no. 12, pp. 9047–9054, 2000.
- L. Elghazi and E. Bernal-Mizrachi, “Akt and PTEN: beta-cell mass and pancreas plasticity,” Trends in Endocrinology and Metabolism, vol. 20, no. 5, pp. 243–251, 2009.
- C. L. Winter, J. S. Lange, M. G. Davis et al., “A nonspecific phosphotyrosine phosphatase inhibitor, bis (maltolato) oxovanadium (IV), improves glucose tolerance and prevents diabetes in Zucker diabetic fatty rats,” Experimental Biology and Medicine, vol. 230, no. 3, pp. 207–216, 2016.
- C. Kang, L. Xie, S. K. Gunasekar et al., “SWELL1 is a glucose sensor regulating β-cell excitability and systemic glycaemia,” Nature Communications, vol. 9, no. 1, p. 367, 2018.
- Y. Kurita, T. Ohki, E. Soejima et al., “A high-fat/high-sucrose diet induces WNT4 expression in mouse pancreatic β-cells,” The Kurume Medical Journal, vol. 65, no. 2, pp. 55–62, 2019.
- J. Liu, X. Wu, J. L. Franklin et al., “MammalianTribbleshomolog 3 impairs insulin action in skeletal muscle: role in glucose-induced insulin resistance,” American Journal of Physiology-Endocrinology and Metabolism, vol. 298, no. 3, pp. E565–E576, 2010.
- S. Oyadomari and M. Mori, “Roles of CHOP/GADD153 in endoplasmic reticulum stress,” Cell Death and Differentiation, vol. 11, no. 4, pp. 381–389, 2004.
- F. Urano, X. Wang, A. Bertolotti et al., “Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1,” Science, vol. 287, no. 5453, pp. 664–666, 2000.
Copyright © 2020 Bo Liang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.